Stock Events

Stock Events

Avalo Therapeutics (AVTX) Q3 2025 Earnings

7AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-2.83

-1.94

-1.06

-0.17

Details

Expected EPS

-1.402229

Actual EPS

-1.92

Surprise EPS

-0.52

Surprise Percent

+36.92%

Description

Avalo Therapeutics (AVTX) has reported earnings of -1.92 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.